T1	Person 0 4	Aged
T2	Value 5 24	between 18-70 years
R1	Has_value Arg1:T1 Arg2:T2	
T3	Measurement 36 108	Diagnostic and Statistical Manual (DSM) IV and DSM-V diagnostic criteria
T4	Scope 26 31	Meets
R2	Has_scope Arg1:T3 Arg2:T4	
T5	Condition 113 141	generalised anxiety disorder
T6	Condition 143 146	GAD
R3	Subsumes Arg1:T5 Arg2:T6	
T7	Procedure 157 177	structured interview
T8	Procedure 179 245	Mini International Neuropsychiatric Interview-Plus 6 [MINI-Plus 6]
R4	Subsumes Arg1:T7 Arg2:T8	
R5	AND Arg1:T7 Arg2:T3	
R6	AND Arg1:T5 Arg2:T7	
T9	Condition 362 369	anxiety
T10	Measurement 371 400	Hamilton Anxiety Rating Scale
T11	Value 401 405	= 18
R7	Has_value Arg1:T10 Arg2:T11	
R8	AND Arg1:T9 Arg2:T10	
T12	Temporal 407 433	at the time of study entry
T13	Reference_point 414 433	time of study entry
R9	Has_index Arg1:T12 Arg2:T13	
R10	Has_temporal Arg1:T9 Arg2:T12	
T14	Non-query-able 435 471	Fluent in written and spoken English
T15	Non-query-able 473 515	Provides a signed copy of the consent form
T16	Condition 546 549	GAD
T17	Condition 517 534	Primary diagnosis
T18	Negation 535 545	other than
R11	Has_negation Arg1:T16 Arg2:T18	
R12	AND Arg1:T17 Arg2:T16	
T19	Qualifier 567 585	moderate to severe
T20	Condition 586 605	depressive symptoms
R13	Has_qualifier Arg1:T20 Arg2:T19	
T21	Scope 567 605	moderate to severe depressive symptoms
T22	Measurement 607 637	Montgomery-Asberg Rating Scale
T23	Measurement 639 644	MADRS
T24	Value 645 649	= 18
R14	Subsumes Arg1:T22 Arg2:T23	
T25	Temporal 650 672	at time of study entry
T26	Value 676 680	= 24
T27	Temporal 681 705	at any time during study
T28	Scope 645 705	= 18 at time of study entry or = 24 at any time during study
R15	Has_temporal Arg1:T24 Arg2:T25	
*	OR T24 T26
R16	Has_temporal Arg1:T26 Arg2:T27	
T29	Scope 607 644	Montgomery-Asberg Rating Scale: MADRS
R17	Has_scope Arg1:T29 Arg2:T28	
T30	Scope 607 705	Montgomery-Asberg Rating Scale: MADRS = 18 at time of study entry or = 24 at any time during study
R18	Subsumes Arg1:T21 Arg2:T30	
T31	Condition 724 741	suicidal ideation
T32	Value 743 746	= 3
T33	Measurement 750 780	MADRS suicidal thoughts domain
T34	Temporal 781 803	at time of study entry
T35	Temporal 807 831	at any time during study
*	OR T34 T35
T36	Scope 781 831	at time of study entry or at any time during study
R19	Has_scope Arg1:T33 Arg2:T36	
R20	Has_value Arg1:T33 Arg2:T32	
T37	Scope 743 831	= 3 on MADRS suicidal thoughts domain at time of study entry or at any time during study
R21	Has_scope Arg1:T31 Arg2:T37	
T38	Condition 855 871	bipolar disorder
T39	Condition 875 888	schizophrenia
T40	Measurement 892 912	structured interview
T41	Measurement 914 923	MINI Plus
R22	Subsumes Arg1:T40 Arg2:T41	
*	OR T39 T38
T42	Scope 855 888	bipolar disorder or schizophrenia
R23	Has_scope Arg1:T40 Arg2:T42	
T43	Condition 944 964	alcohol use disorder
T44	Condition 934 943;952 964	substance use disorder
T45	Measurement 968 988	structured interview
T46	Measurement 990 999	MINI Plus
R24	Subsumes Arg1:T45 Arg2:T46	
*	OR T44 T43
T47	Scope 934 964	substance/alcohol use disorder
R25	Has_scope Arg1:T45 Arg2:T47	
T48	Drug 1061 1075	antidepressant
T49	Condition 1051 1057	taking
T50	Temporal 1041 1050	Currently
R27	Has_temporal Arg1:T49 Arg2:T50	
T51	Drug 1077 1092	mood stabiliser
T52	Drug 1094 1107	antipsychotic
T53	Drug 1109 1123	anticonvulsant
T54	Drug 1125 1133	warfarin
T55	Drug 1137 1145	thyroxin
T56	Drug 1203 1217	benzodiazepine
T57	Drug 1221 1243	opioid-based analgesic
*	OR T56 T57
T58	Multiplier 1171 1196	more than 2 days per week
T59	Multiplier 1158 1165	regular
T60	Temporal 1150 1157	current
T61	Scope 1203 1243	benzodiazepine or opioid-based analgesic
R29	Subsumes Arg1:T59 Arg2:T58	
*	OR T55 T54 T53 T52 T51 T48
T62	Scope 1061 1145	antidepressant, mood stabiliser, antipsychotic, anticonvulsant, warfarin or thyroxin
R26	Has_scope Arg1:T49 Arg2:T62	
T63	Procedure 1166 1169	use
R31	Has_multiplier Arg1:T63 Arg2:T59	
R28	Has_temporal Arg1:T63 Arg2:T60	
R30	Has_scope Arg1:T63 Arg2:T61	
*	OR T63 T49
T64	Drug 1262 1288	psychotropic nutraceutical
T65	Condition 1295 1309	St John's wort
T66	Temporal 1245 1252	Current
T67	Procedure 1253 1256	use
R32	AND Arg1:T67 Arg2:T64	
R33	Has_temporal Arg1:T67 Arg2:T66	
R34	Subsumes Arg1:T64 Arg2:T65	
T68	Condition 1321 1332	intolerance
T69	Drug 1336 1340	kava
R35	AND Arg1:T68 Arg2:T69	
T70	Temporal 1312 1320	Previous
R36	Has_temporal Arg1:T68 Arg2:T70	
T71	Multiplier 1342 1355	Three or more
T72	Procedure 1363 1388	trials of pharmacotherapy
T73	Qualifier 1356 1362	failed
T74	Condition 1405 1416	GAD episode
T75	Temporal 1397 1404	current
R37	Has_qualifier Arg1:T72 Arg2:T73	
R38	Has_multiplier Arg1:T72 Arg2:T71	
R39	AND Arg1:T72 Arg2:T74	
R40	Has_temporal Arg1:T74 Arg2:T75	
T76	Procedure 1437 1450	psychotherapy
T77	Temporal 1452 1484	within four weeks of study entry
T78	Temporal 1418 1426	Recently
R41	Subsumes Arg1:T78 Arg2:T77	
R42	Has_temporal Arg1:T76 Arg2:T78	
T79	Qualifier 1506 1525	clinically unstable
T80	Qualifier 1526 1534	systemic
T81	Condition 1535 1551	medical disorder
R43	Has_qualifier Arg1:T81 Arg2:T80	
R44	Has_qualifier Arg1:T81 Arg2:T79	
T82	Mood 1496 1505	suspected
T83	Mood 1487 1492	Known
*	OR T82 T83
T84	Scope 1487 1505	Known or suspected
R45	Has_scope Arg1:T81 Arg2:T84	
T85	Condition 1563 1585	hepato-biliary disease
T86	Condition 1563 1577;1586 1598	hepato-biliary inflammation
*	OR T85 T86
T87	Value 1600 1608	Elevated
T88	Measurement 1609 1622	liver enzymes
T89	Temporal 1626 1634	baseline
T90	Procedure 1635 1645	blood test
R46	Has_temporal Arg1:T90 Arg2:T89	
R47	Has_value Arg1:T88 Arg2:T87	
R48	AND Arg1:T88 Arg2:T90	
T91	Condition 1647 1656	Pregnancy
T92	Observation 1660 1673	breastfeeding
*	OR T92 T91 T93
T93	Condition 1678 1696	trying to conceive
T94	Negation 1698 1701	Not
T96	Qualifier 1708 1726	medically approved
T97	Procedure 1727 1740	contraception
R49	Has_qualifier Arg1:T97 Arg2:T96	
T98	Procedure 1752 1762	abstinence
R50	Subsumes Arg1:T97 Arg2:T98	
T99	Person 1767 1773	female
T100	Person 1781 1797	childbearing age
T101	Observation 1794 1797	age
T102	Value 1781 1793	childbearing
R51	Has_value Arg1:T101 Arg2:T102	
T103	Scope 1781 1797	childbearing age
R52	multi Arg1:T100 Arg2:T103	
T104	Scope 1767 1797	female and of childbearing age
A1	Optional T104
R53	Has_negation Arg1:T97 Arg2:T94	
T105	Scope 1698 1763	Not using medically approved contraception (including abstinence)
R54	Has_scope Arg1:T104 Arg2:T105	
T95	Observation 1799 1820	Unable to participate
T106	Visit 1828 1844	scheduled visits
T107	Observation 1846 1860	treatment plan
T108	Procedure 1871 1887	trial procedures
*	OR T106 T107 T108
T109	Negation 1915 1925	except for
T110	Observation 1939 1956	genetic component
R55	Has_negation Arg1:T110 Arg2:T109	
T111	Scope 1828 1887	scheduled visits, treatment plan, or other trial procedures
R56	Has_context Arg1:T111 Arg2:T110	
R57	Has_context Arg1:T111 Arg2:T95	
